What is the best pharmacologic treatment for sickle cell disease pain crises? （開啟新視窗）

Baker M, Hafner JW.

來源‎: Ann Emerg Med 2012;59(6):515-6.

檢索‎: PubMed 22221839

DOI碼‎: 10.1016/j.annemergmed.2011.11.026

https://www.ncbi.nlm.nih.gov/pubmed/22221839 （開啟新視窗）

Update on pain management in sickle cell disease. （開啟新視窗）

Ballas SK.

來源‎: Hemoglobin 2011;35(5-6):520-9.

檢索‎: PubMed 21910604

DOI碼‎: 10.3109/03630269.2011.610478

https://www.ncbi.nlm.nih.gov/pubmed/21910604 （開啟新視窗）

Reduction of painful vaso-occlusive crisis of sickle cell anaemia by tinzaparin in a double-blind randomized trial. （開啟新視窗）

Qari MH, Aljaouni SK, Alardawi MS, Fatani H, Alsayes FM, Zografos P, Alsaigh M, Alalfi A, Alamin M, Gadi A, Mousa SA.

來源‎: Thromb Haemost 2007;98(2):392-6.

檢索‎: PubMed 17721622

https://www.ncbi.nlm.nih.gov/pubmed/17721622 （開啟新視窗）

Adult emergency department patients with sickle cell pain crisis: results from a quality improvement learning collaborative model to improve analgesic management. （開啟新視窗）

Tanabe P, Hafner JW, Martinovich Z, Artz N.

來源‎: Acad Emerg Med 2012;19(4):430-8.

檢索‎: PubMed 22506947

DOI碼‎: 10.1111/j.1553-2712.2012.01330.x

https://www.ncbi.nlm.nih.gov/pubmed/22506947 （開啟新視窗）

Management of sickle cell disease. （開啟新視窗）

de Montalembert M.

來源‎: BMJ 2008;337:a1397.

檢索‎: PubMed 18779222

https://www.ncbi.nlm.nih.gov/pubmed/18779222 （開啟新視窗）

Fluid replacement therapy for acute episodes of pain in people with sickle cell disease. （開啟新視窗）

Okomo U, Meremikwu MM.

來源‎: Cochrane Database Syst Rev 2012;(6):CD005406.

檢索‎: PubMed 22696351

DOI碼‎: 10.1002/14651858.CD005406.pub3

https://www.ncbi.nlm.nih.gov/pubmed/22696351 （開啟新視窗）

Low flow nocturnal oxygen therapy does not suppress haemoglobin levels or increase painful crises in sickle cell disease. （開啟新視窗）

Ip H, Kesse-Adu R, Howard J, Hart N.

來源‎: Br J Haematol 2013;161(3):455-6.

檢索‎: PubMed 23419066

DOI碼‎: 10.1111/bjh.12254

https://www.ncbi.nlm.nih.gov/pubmed/23419066 （開啟新視窗）

Guidelines for the management of the acute painful crisis in sickle cell disease. （開啟新視窗）

Rees DC, Olujohungbe AD, Parker NE, Stephens AD, Telfer P, Wright J; British Committee for Standards in Haematology General Haematology Task Force by the Sickle Cell Working Party.

來源‎: Br J Haematol 2003;120(5):744-52.

檢索‎: PubMed 12614204

https://www.ncbi.nlm.nih.gov/pubmed/12614204 （開啟新視窗）

Hyperbaric oxygen therapy for vaso-occlusive crises in nine patients with sickle-cell disease. （開啟新視窗）

Stirnemann J, Letellier E, Aras N, Borne M, Brinquin L, Fain O.

來源‎: Diving Hyperb Med 2012;42(2):82-4.

檢索‎: PubMed 22828815

https://www.ncbi.nlm.nih.gov/pubmed/22828815 （開啟新視窗）

Safety of purified poloxamer 188 in sickle cell disease: phase I study of a non-ionic surfactant in the management of acute chest syndrome. （開啟新視窗）

Ballas SK, Files B, Luchtman-Jones L, Benjamin L, Swerdlow P, Hilliard L, Coates T, Abboud M, Wojtowicz-Praga S, Grindel JM.

來源‎: Hemoglobin 2004;28(2):85-102.

檢索‎: PubMed 15182051

https://www.ncbi.nlm.nih.gov/pubmed/15182051 （開啟新視窗）

Incentive spirometry to prevent acute pulmonary complications in sickle cell diseases. （開啟新視窗）

Bellet PS, Kalinyak KA, Shukla R, Gelfand MJ, Rucknagel DL.

來源‎: N Engl J Med 1995;333(11):699-703.

檢索‎: PubMed 7637747

DOI碼‎: 10.1056/NEJM199509143331104

https://www.ncbi.nlm.nih.gov/pubmed/7637747 （開啟新視窗）

Continuous inhaled nitric oxide therapy in a case of sickle cell disease with multiorgan involvement. （開啟新視窗）

Chang WL, Corate LM, Sinclair JM, van der Heyde HC.

來源‎: J Investig Med 2008;56(8):1023-7.

檢索‎: PubMed 19050460

DOI碼‎: 10.2310/JIM.0b013e31818cb612

https://www.ncbi.nlm.nih.gov/pubmed/19050460 （開啟新視窗）

Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. （開啟新視窗）

Vichinsky EP, Neumayr LD, Earles AN, Williams R, Lennette ET, Dean D, Nickerson B, Orringer E, McKie V, Bellevue R, Daeschner C, Manci EA.

來源‎: N Engl J Med 2000;342(25):1855-65.

檢索‎: PubMed 10861320

DOI碼‎: 10.1056/NEJM200006223422502

https://www.ncbi.nlm.nih.gov/pubmed/10861320 （開啟新視窗）